GSK
GSK plcCompany with tickers: GSK, GLAXF
CIK
1131399
CUSIP
37733W204
Shares Outstanding
2,004,414,458
Website
https://www.gsk.com/
Investor Relations
https://www.gsk.com/investor-relations
13F Activity (30d)
319 filings
306 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2020-07-13 | — | |
| 6-K | 2020-07-14 | — | |
| 6-K | 2020-07-15 | — | |
| 6-K | 2020-07-20 | — | |
| 6-K | 2020-07-24 | — | |
| 6-K | 2020-07-28 | — | |
| 6-K | 2020-07-29 | — | |
| 6-K | 2020-07-31 | — | |
| 6-K | 2020-08-03 | — | |
| 6-K | 2020-08-06 | — | |
| 6-K | 2020-08-13 | — | |
| 6-K | 2020-09-01 | — | |
| 6-K | 2020-09-03 | — | |
| 6-K | 2020-09-09 | — | |
| 6-K | 2020-09-10 | — | |
| 6-K | 2020-09-11 | — | |
| 6-K | 2020-09-22 | — | |
| 6-K | 2020-09-28 | — | |
| 6-K | 2020-10-01 | — | |
| 6-K | 2020-10-13 | — | |
| 6-K | 2020-10-14 | — | |
| 6-K | 2020-10-16 | — | |
| 6-K | 2020-10-22 | — | |
| 6-K | 2020-10-28 | — | |
| 6-K | 2020-10-30 | — | |
| 6-K | 2020-11-02 | — | |
| 6-K | 2020-11-03 | — | |
| 6-K | 2020-11-04 | — | |
| 6-K | 2020-11-09 | — | |
| 6-K | 2020-11-12 | — | |
| 6-K | 2020-11-17 | — | |
| 6-K | 2020-11-19 | — | |
| 6-K | 2020-11-23 | — | |
| 6-K | 2020-11-25 | — | |
| 6-K | 2020-11-27 | — | |
| 6-K | 2020-12-01 | — | |
| 6-K | 2020-12-03 | — | |
| 6-K | 2020-12-09 | — | |
| 6-K | 2020-12-10 | — | |
| 6-K | 2020-12-11 | — | |
| 6-K | 2020-12-21 | — | |
| 6-K | 2020-12-23 | — | |
| 6-K | 2020-12-30 | — | |
| 6-K | 2021-01-04 | — | |
| 6-K | 2021-01-11 | — | |
| 6-K | 2021-01-13 | — | |
| 6-K | 2021-01-15 | — | |
| 6-K | 2021-01-19 | — | |
| 6-K | 2021-01-20 | — | |
| 6-K | 2021-01-22 | — |
Showing 51–100 of 835 filings